ILLNESS of HUMAN
That we know about illnesses
Wednesday, 04 May 2016
You know that ...
At a birth in a body of the child of the order of 300 bones, by their old age remains only 206.
CARCINOID

Carcinoid (carcinoid syndrome) - seldom meeting potentially malignant hormonal-active tumour occuring from chromaffin cells. Primary localization of this tumour - in a process in the form of a worm, less often in ileal, thick (especially direct) intestine, even less often - in a stomach, a cholic bubble, a pancreas; exclusively seldom arises in bronchuses, an ovary and other organs.

Etiology. The parentage of many signs of disease is caused by hormonal activity of a tumour.

Signs, current. The clinical picture develops of the local signs caused by the tumour, and the so-called carcinoid syndrome caused by its hormonal activity. Local morbidity is taped; the attributes reminding acute or an appendicism (are quite often marked at the most frequent localization of a tumour in a process in the form of a worm) or signs of an intestinal obstruction, an intestinal bleeding (at localization in thin or a colon), a pain at a defecation and allocation with a feces of a scarlet blood (at a carcinoid of a rectum), growing thin. The carcinoid syndrome includes original vasculomotor reactions, attacks of a bronchospasm, a hyperperistalsis of a gastrointestinal tract, characteristic changes of a skin, a lesion of heart and a pulmonary artery. In the expressed form it is observed not at all patients, more often - at the metastasises of a tumour especially plural, in a liver and other organs. The most typical display of a carcinoid syndrome - a sudden short-term erubescence of the face, the top half of the trunk, accompanied the general delicacy, sensation of fever, a tachycardia, a hypotension, sometimes a dacryagogue, a rhinitis, a bronchospasm, a nausea and a vomiting, diarrhea and a colicy pain in a stomach.

News of medicine
01.05.2016 MTX Dose Can Be Kept Low When Combined With Enbrel in RA (CME/CE) >>>
30.04.2016 D.C. Week: Medicare Reforms Backed Up With New Rules >>>
30.04.2016 Neurological Symptoms Strike One in Five Primary Sjogren Patients (CME/CE) >>>
30.04.2016 Marketing City Smells: That's Improbable! >>>
30.04.2016 FDA OKs Pimavanserin for Hallucinations in Parkinson's >>>
30.04.2016 How to Build Rapport With a Physician Recruiter >>>
30.04.2016 'Stop Hunting Zebras': What We Heard This Week >>>
30.04.2016 Friday Feedback: The Continuing Problem of Opioids and Pain >>>
30.04.2016 Late Diagnosis, Adherence to Tx Problematic for Latinos With HIV >>>
30.04.2016 QRISK2: A Reliable Cardiovascular Risk Calculator >>>
29.04.2016 Septal Reduction Volumes; Primary Prevention Meds; 'Smoker's Paradox' >>>
29.04.2016 Drug-Coated Balloons: Where Is the Benefit? (CME/CE) >>>
29.04.2016 Age, Disease Duration Predict Anti-TNF Use in AS >>>
29.04.2016 Room for Improvement in Emergency Surgery Quality >>>
29.04.2016 EndoBreak: Apple's Diabetes App; Pop-Star Soda Controversy >>>
29.04.2016 Twin Study Ties Psoriasis to Diabetes, Obesity (CME/CE) >>>
29.04.2016 Gout and Osteoarthritis: Is There a Link? (CME/CE) >>>
29.04.2016 New York Slashes Opioid Use in Childbearing-Age Women >>>
29.04.2016 Actemra's Benefits Hold Up for 5 Years in JIA (CME/CE) >>>
28.04.2016 New Medicare Rules Would Increase Bonus Opportunities, Ease Reporting >>>